
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 192 pages)
“Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics”, N Engl J Med, vol. 349, pp. 1628-35, 2003.
, “Antibiotic treatment of acne may be associated with upper respiratory tract infections”, Arch Dermatol, vol. 141, pp. 1132-6, 2005.
, “Association between the use of beta-adrenergic receptor agents and the development of venous leg ulcers”, Arch Dermatol, vol. 143, pp. 1275-80, 2007.
, “Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol”, Br J Clin Pharmacol, vol. 58, pp. 81-7, 2004.
, “Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers”, Lancet, vol. 359, pp. 675-7, 2002.
, “Immunosuppressant medications and mortality in inflammatory bowel disease”, Am J Gastroenterol, vol. 103, pp. 1428-35; quiz 1436, 2008.
, “The incidence and prevalence of pressure ulcers among elderly patients in general medical practice”, Ann Epidemiol, vol. 12, pp. 321-5, 2002.
, “Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom”, Arch Dermatol, vol. 139, pp. 1425-9, 2003.
, “Medical conditions as risk factors for pressure ulcers in an outpatient setting”, Age Ageing, vol. 32, pp. 259-64, 2003.
, “Medical conditions associated with venous leg ulcers”, Br J Dermatol, vol. 150, pp. 267-73, 2004.
, “Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes”, BMJ Open Diabetes Res Care, vol. 5, p. e000400, 2017.
, “Prevalence and treatment of psoriasis in the United Kingdom: a population-based study”, Arch Dermatol, vol. 141, pp. 1537-41, 2005.
, “Represcription of penicillin after allergic-like events”, J Allergy Clin Immunol, vol. 113, pp. 764-70, 2004.
, “The risk of lymphoma in patients with psoriasis”, J Invest Dermatol, vol. 126, pp. 2194-201, 2006.
, “The risk of mortality in patients with psoriasis: results from a population-based study”, Arch Dermatol, vol. 143, pp. 1493-9, 2007.
, “Risk of myocardial infarction in patients with psoriasis”, Jama, vol. 296, pp. 1735-41, 2006.
, “Is there cross-reactivity between penicillins and cephalosporins?”, Am J Med, vol. 119, pp. 354.e11-9, 2006.
, “Upper respiratory tract infection in household contacts of acne patients”, Dermatology, vol. 215, pp. 213-8, 2007.
, “Venous leg ulcer: incidence and prevalence in the elderly”, J Am Acad Dermatol, vol. 46, pp. 381-6, 2002.
,